Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Specials
Links
About
Last issue
All issues
Newsletters
Subscribe
Table of Contents:
Bone health in cancer
Delirium in adult cancer patients: BSMO Guidelines
Current treatment patterns of advanced hormone receptor-positive, HER2-negative breast cancer in Belgium
Mazabraud’s Syndrome in association with other benign soft tissue tumours: A case report
Breast cancer in a young woman with short stature: Which diagnosis not to miss
ESOU22: Updates on GU cancers and meeting highlights
De-escalation of therapy in head and neck cancer: Where are we standing now,
anno
2022?
New oncology reimbursements in Belgium
Read online
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
News
>
General
>
Immuno-oncology choices and therapy management in metastatic renal cell carcinoma
Immuno-oncology choices and therapy management in metastatic renal cell carcinoma
February 2021
General
Ariez
To view this article please log in on top of screen.
Share this article
Share
Tweet
Share
Email
Share
X